Cargando…

Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke

BACKGROUND: Early recanalization of occluded vessels in stroke is closely associated with improved clinical outcome. Microbubble-enhanced sonothrombolysis is a promising therapy to improve recanalization rates and reduce the time to recanalization. Testing any thrombolytic therapy requires a model o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomkins, Amelia J, Schleicher, Nadine, Murtha, Lucy, Kaps, Manfred, Levi, Christopher R, Nedelmann, Max, Spratt, Neil J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318170/
https://www.ncbi.nlm.nih.gov/pubmed/25657829
http://dx.doi.org/10.1186/s13231-014-0014-y
_version_ 1782355814877495296
author Tomkins, Amelia J
Schleicher, Nadine
Murtha, Lucy
Kaps, Manfred
Levi, Christopher R
Nedelmann, Max
Spratt, Neil J
author_facet Tomkins, Amelia J
Schleicher, Nadine
Murtha, Lucy
Kaps, Manfred
Levi, Christopher R
Nedelmann, Max
Spratt, Neil J
author_sort Tomkins, Amelia J
collection PubMed
description BACKGROUND: Early recanalization of occluded vessels in stroke is closely associated with improved clinical outcome. Microbubble-enhanced sonothrombolysis is a promising therapy to improve recanalization rates and reduce the time to recanalization. Testing any thrombolytic therapy requires a model of thromboembolic stroke, but to date these models have been highly variable with regards to clot stability. Here, we developed a model of thromboembolic stroke in rats with site-specific delivery of platelet-rich clots (PRC) to the main stem of the middle cerebral artery (MCA). This model was used in a subsequent study to test microbubble-enhanced sonothrombolysis. METHODS: In Study 1 we investigated spontaneous recanalization rates of PRC in vivo over 4 hours and measured infarct volumes at 24 hours. In Study 2 we investigated tPA-mediated thrombolysis and microbubble-enhanced sonothrombolysis in this model. RESULTS: Study 1 demonstrated stable occlusion out to 4 hours in 5 of 7 rats. Two rats spontaneously recanalized at 40 and 70 minutes post-embolism. Infarct volumes were not significantly different in recanalized rats, 43.93 ± 15.44% of the ischemic hemisphere, compared to 48.93 ± 3.9% in non-recanalized animals (p = 0.7). In Study 2, recanalization was not observed in any of the groups post-treatment. CONCLUSIONS: Site specific delivery of platelet rich clots to the MCA origin resulted in high rates of MCA occlusion, low rates of spontaneous clot lysis and large infarction. These platelet rich clots were highly resistant to tPA with or without microbubble-enhanced sonothrombolysis. This resistance of platelet rich clots to enhanced thrombolysis may explain recanalization failures clinically and should be an impetus to better clot-type identification and alternative recanalization methods. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13231-014-0014-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4318170
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43181702015-02-06 Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke Tomkins, Amelia J Schleicher, Nadine Murtha, Lucy Kaps, Manfred Levi, Christopher R Nedelmann, Max Spratt, Neil J Exp Transl Stroke Med Research BACKGROUND: Early recanalization of occluded vessels in stroke is closely associated with improved clinical outcome. Microbubble-enhanced sonothrombolysis is a promising therapy to improve recanalization rates and reduce the time to recanalization. Testing any thrombolytic therapy requires a model of thromboembolic stroke, but to date these models have been highly variable with regards to clot stability. Here, we developed a model of thromboembolic stroke in rats with site-specific delivery of platelet-rich clots (PRC) to the main stem of the middle cerebral artery (MCA). This model was used in a subsequent study to test microbubble-enhanced sonothrombolysis. METHODS: In Study 1 we investigated spontaneous recanalization rates of PRC in vivo over 4 hours and measured infarct volumes at 24 hours. In Study 2 we investigated tPA-mediated thrombolysis and microbubble-enhanced sonothrombolysis in this model. RESULTS: Study 1 demonstrated stable occlusion out to 4 hours in 5 of 7 rats. Two rats spontaneously recanalized at 40 and 70 minutes post-embolism. Infarct volumes were not significantly different in recanalized rats, 43.93 ± 15.44% of the ischemic hemisphere, compared to 48.93 ± 3.9% in non-recanalized animals (p = 0.7). In Study 2, recanalization was not observed in any of the groups post-treatment. CONCLUSIONS: Site specific delivery of platelet rich clots to the MCA origin resulted in high rates of MCA occlusion, low rates of spontaneous clot lysis and large infarction. These platelet rich clots were highly resistant to tPA with or without microbubble-enhanced sonothrombolysis. This resistance of platelet rich clots to enhanced thrombolysis may explain recanalization failures clinically and should be an impetus to better clot-type identification and alternative recanalization methods. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13231-014-0014-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-27 /pmc/articles/PMC4318170/ /pubmed/25657829 http://dx.doi.org/10.1186/s13231-014-0014-y Text en © Tomkins et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Tomkins, Amelia J
Schleicher, Nadine
Murtha, Lucy
Kaps, Manfred
Levi, Christopher R
Nedelmann, Max
Spratt, Neil J
Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
title Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
title_full Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
title_fullStr Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
title_full_unstemmed Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
title_short Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
title_sort platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318170/
https://www.ncbi.nlm.nih.gov/pubmed/25657829
http://dx.doi.org/10.1186/s13231-014-0014-y
work_keys_str_mv AT tomkinsameliaj plateletrichclotsareresistanttolysisbythrombolytictherapyinaratmodelofembolicstroke
AT schleichernadine plateletrichclotsareresistanttolysisbythrombolytictherapyinaratmodelofembolicstroke
AT murthalucy plateletrichclotsareresistanttolysisbythrombolytictherapyinaratmodelofembolicstroke
AT kapsmanfred plateletrichclotsareresistanttolysisbythrombolytictherapyinaratmodelofembolicstroke
AT levichristopherr plateletrichclotsareresistanttolysisbythrombolytictherapyinaratmodelofembolicstroke
AT nedelmannmax plateletrichclotsareresistanttolysisbythrombolytictherapyinaratmodelofembolicstroke
AT sprattneilj plateletrichclotsareresistanttolysisbythrombolytictherapyinaratmodelofembolicstroke